PHARMARESEARCH BIO Co., Ltd.

A217950

KR7217950005

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-16 EDT			5-day change	1st Jan Change
29,750 ^KRW	-1.16%		-2.14%	+48.01%

02-22	PHARMARESEARCH BIO Co., Ltd. announced that it has received KRW 10 billion in funding from Shinhan Capital Co., Ltd.	CI
02-19	PHARMARESEARCH BIO Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Shinhan Capital Co., Ltd.	CI

BIOCND Inc. announced that it has received KRW 10 billion in funding from Pharma Research Products Co., Ltd

April 02, 2018

On April 3, 2018, BIOCND Inc. (XKON:A217950) closed the transaction.

Latest news about PHARMARESEARCH BIO Co., Ltd.

PHARMARESEARCH BIO Co., Ltd. announced that it has received KRW 10 billion in funding from Shinhan Capital Co., Ltd.	02-21	CI
PHARMARESEARCH BIO Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Shinhan Capital Co., Ltd.	02-18	CI
PHARMA RESEARCH BIO Co., Ltd. announced that it has received KRW 30 billion in funding from PharmaResearch Co., Ltd.	21-11-25	CI
PHARMA RESEARCH BIO Co., Ltd. announced that it expects to receive KRW 30 billion in funding from PharmaResearch Co., Ltd.	21-11-23	CI
Dongho Song cancelled the acquisition of G Biologics Co., Ltd. from PHARMA RESEARCH BIO Co., Ltd..	19-06-28	CI
Dongho Song agreed to acquire G Biologics Co., Ltd. from PHARMA RESEARCH BIO Co., Ltd. for KRW 5.2 billion.	18-06-28	CI
Sangsoo Jung and others acquired 26.2% stake in Pharma Research Bio Co., Ltd. from Dong-Ho Song for KRW 16.5 billion.	18-04-03	CI
Dong-Ho Song acquired an additional 0.034% stake in Pharma Research Bio Co., Ltd. from KDB Capital Corp.for KRW 30.5 million.	18-04-03	CI
Dong-Ho Song acquired an additional 1.9% stake in Pharma Research Bio Co., Ltd. from KDB Capital Corp.for KRW 1.7 billion.	18-04-03	CI
Dong-Ho Song acquired an additional 2.8% stake in Pharma Research Bio Co., Ltd. from Meritz Securities Co., Ltd, Investment Arm for KRW 2.2 billion.	18-04-03	CI
Sangsoo Jung and others acquired 26.2% in Pharma Research Bio Co., Ltd. from Dong-Ho Song for KRW 16.5 billion.	18-04-03	CI
BIOCND Inc. announced that it has received KRW 10 billion in funding from Pharma Research Products Co., Ltd	18-04-02	CI
Pharma Research Products Co., Ltd completed the acquisition of 42.45% stake in BIOCND Inc. from a group of shareholders.	18-03-27	CI
BIOCND Inc. announced that it expects to receive KRW 10 billion in funding from Pharma Research Products Co., Ltd	18-01-25	CI
Pharma Research Products Co., Ltd signed a memorandum of understanding to acquire 42.45% stake in BIOCND Inc. from a group of shareholders for KRW 25.9 billion.	17-11-28	CI
PHARMA RESEARCH BIO Co., Ltd. announced that it has received KRW 1.5 billion in funding	17-07-19	CI
PHARMA RESEARCH BIO Co., Ltd. announced that it has received KRW 1 billion in funding from Dt& Investment Co.,Ltd.	17-06-28	CI
PHARMA RESEARCH BIO Co., Ltd. announced that it expects to receive KRW 1 billion in funding from Dt& Investment Co.,Ltd.	17-06-27	CI
BIOCND Inc. completed the acquisition of remaining 60.12% stake in Wonjin BCD Co., Ltd.	17-02-12	CI
BIOCND Inc. signed a merger contract to acquire remaining 60.12% stake in Wonjin BCD Co., Ltd.	16-11-28	CI
BIOCND Inc. cancelled the acquisition of remaining minority stake in Wonjin BCD Co., Ltd.	16-10-24	CI
BIOCND Inc. signed a merger contract to acquire remaining minority stake in Wonjin BCD Co., Ltd.	16-09-08	CI
Jooyeon Lee acquired 0.01% stake in Pharma Research Bio Co., Ltd. from Hokg-ki Min for KRW 0.25 million.	16-08-04	CI
Kyungeun Yoon acquired 0.014% stake in Pharma Research Bio Co., Ltd. from Hong-Ki Min for KRW 12 million.	15-12-17	CI

Chart PHARMARESEARCH BIO Co., Ltd.

Duration

Period

More charts

PharmaResearch Bio Co Ltd, formerly Pharma Research Bio Co Ltd, is a Korea-based company is principally engaged in the research, development and production of biological drugs. The Company is mainly engaged in the research, development and production of botulinum toxin prescription drugs. The Company distributes its products within domestic market and to overseas markets including China and the United Kingdom.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
PHARMARESEARCH BIO CO., LTD.	+48.01%	88.97M
VERTEX PHARMACEUTICALS INCORPORATED	+9.42%	115B
REGENERON PHARMACEUTICALS, INC.	+11.84%	106B
BIONTECH SE	-14.15%	21.84B
ARGENX SE	-1.05%	21.96B
GENMAB A/S	-5.29%	19.21B
WUXI APPTEC CO., LTD.	-38.29%	17.71B
BEIGENE, LTD.	-4.16%	18.08B
NEUROCRINE BIOSCIENCES, INC.	+7.99%	14.32B
SAREPTA THERAPEUTICS, INC.	+36.24%	12.42B

Bio Therapeutic Drugs

PHARMARESEARCH BIO Co., Ltd.

Equities

A217950

KR7217950005

Biotechnology & Medical Research

BIOCND Inc. announced that it has received KRW 10 billion in funding from Pharma Research Products Co., Ltd

Latest news about PHARMARESEARCH BIO Co., Ltd.

Chart PHARMARESEARCH BIO Co., Ltd.

Company Profile

Sector Bio Therapeutic Drugs